Evidence map›Paper›PMID 32930852›Full record

ReviewSeminars in immunopathology2020

Immunosenescence is both functional/adaptive and dysfunctional/maladaptive.

T Fulop, A Larbi, K Hirokawa, A A Cohen, J M Witkowski

Open access · bronzeAbstract readReview
In one paragraph

Review in Seminars in immunopathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Renaissance of antiviral CD8Nature reviews. Immunology · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Inflammaging and the sex-frailty paradox.Aging clinical and experimental research · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Peripheral CD4Immunity & ageing : I & A · 2024
    Article
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

T FulopDepartment of Geriatrics, Faculty of Medicine, Research Center on Aging, University of Sherbrooke, Sherbrooke, QC, J1K 2R1, Canada. Tamas.Fulop@Usherbrooke.ca.ORCID 0000-0001-5835-7449
A LarbiBiology of Aging Program and Immunomonitoring Platform, Singapore Immunology Network (SIgN), Agency for Science Technology and Research (A*STAR), Immunos Building, Biopolis, Singapore, 138648, Singapore.
K HirokawaInstitute of Health and Life Science, Tokyo and Nito-memory Nakanosogo Hospital, Department of Pathology, Tokyo Med. Dent. University, Tokyo, Japan.
A A CohenDepartment of Family Medicine, Faculty of Medicine, Research Center on Aging, University of Sherbrooke, Sherbrooke, QC, J1K 2R1, Canada.
J M WitkowskiDepartment of Pathophysiology, Medical University of Gdansk, Gdansk, Poland.
Université de Sherbrooke · CAAgency for Science, Technology and Research · SGGdańsk Medical University · PLNitobe Memorial Nakano General Hospital · JP

Funding

CIHR 106634
6 · The paper itself

Abstract

Alterations in the immune system with aging are considered to underlie many age-related diseases. However, many elderly individuals remain healthy until even a very advanced age. There is also an increase in numbers of centenarians and their apparent fitness. We should therefore change our unilaterally detrimental consideration of age-related immune changes. Recent data taking into consideration the immunobiography concept may allow for meaningful distinctions among various aging trajectories. This implies that the aging immune system has a homeodynamic characteristic balanced between adaptive and maladaptive aspects. The survival and health of an individual depends from the equilibrium of this balance. In this article, we highlight which parts of the aging of the immune system may be considered adaptive in contrast to those that may be maladaptive.

Indexed as

ImmunosenescenceAgedAged, 80 and overAgingHumansImmune SystemAdaptationCentenariansImmunosenescenceImmunosuppressive mechanismsInflammagingMaladaptationTrained immunity

Identifiers

PMID32930852
PMCPMC7490574
OpenAlexW3087117789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.